Literature DB >> 22989890

14-3-3ζ Protein regulates anterograde transport of the human κ-opioid receptor (hKOPR).

Jian-Guo Li1, Chongguang Chen, Peng Huang, Yujun Wang, Lee-Yuan Liu-Chen.   

Abstract

By proteomic analysis, we found that 14-3-3ζ was one of the proteins co-immunoprecipitated with human κ-opioid receptor (hKOPR) from extracts of solubilized Neuro2A cells stably expressing FLAG-hKOPR (N2A-FLAG-hKOPR cells). 14-3-3 proteins are a family of conserved regulatory molecules in eukaryotic cells, where they participate in signal transduction, metabolism, and membrane protein transport. 14-3-3ζ co-localized with the hKOPR in N2A cells. The hKOPR C-tail interacted with 14-3-3ζ in rat brain extracts and bound directly to purified 14-3-3ζ as demonstrated by pulldown techniques. 14-3-3ζ siRNA decreased expression of the hKOPR in N2A-FLAG-hKOPR cells and cultured primary cortical neurons of E19 rats by ~25% as determined by immunoblotting, ligand binding, and flow cytometry. The effect of 14-3-3ζ siRNA was reversed by overexpression of 14-3-3ζ. Expression of the 14-3-3 scavenger protein pGpLI-R18 also decreased hKOPR expression. 14-3-3ζ siRNA did not change expressions of the hDOPR and rMOPR in N2A cells. Pulse-chase study showed that 14-3-3ζ siRNA decreased the amount of mature hKOPR but did not change the rate of maturation or stability of hKOPR protein. Mutations of R354A/S358A in the putative 14-3-3 interaction motif (354)RQSTS(358) in the hKOPR C-tail reduced interaction of the hKOPR with 14-3-3ζ and abolished the effect of 14-3-3ζ knockdown on hKOPR expression. Mutation of the endoplasmic reticulum retention motif (359)RVR adjacent to the 14-3-3 interaction motif in the hKOPR C-tail decreased interaction of coatomer protein I (COPI) with the hKOPR and abolished 14-3-3ζ-mediated regulation of hKOPR expression. 14-3-3ζ knockdown increased association of COPI with the hKOPR. These results suggest that 14-3-3ζ promotes expression of the hKOPR by inhibiting COPI and RVR motif-mediated endoplasmic reticulum localization machinery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22989890      PMCID: PMC3488053          DOI: 10.1074/jbc.M112.359679

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  14-3-3 proteins: regulation of endoplasmic reticulum localization and surface expression of membrane proteins.

Authors:  Sojin Shikano; Brian Coblitz; Meng Wu; Min Li
Journal:  Trends Cell Biol       Date:  2006-07       Impact factor: 20.808

2.  Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members.

Authors:  Nathan J Gödde; Giovanna M D'Abaco; Lucy Paradiso; Ulrike Novak
Journal:  J Cell Sci       Date:  2006-07-25       Impact factor: 5.285

Review 3.  14-3-3 proteins in membrane protein transport.

Authors:  Thomas Mrowiec; Blanche Schwappach
Journal:  Biol Chem       Date:  2006-09       Impact factor: 3.915

Review 4.  Regulation of receptor trafficking by GRKs and arrestins.

Authors:  Catherine A C Moore; Shawn K Milano; Jeffrey L Benovic
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

Review 5.  Regulation of G protein-coupled receptor export trafficking.

Authors:  Chunmin Dong; Catalin M Filipeanu; Matthew T Duvernay; Guangyu Wu
Journal:  Biochim Biophys Acta       Date:  2006-09-23

6.  Scavenging of 14-3-3 proteins reveals their involvement in the cell-surface transport of ATP-sensitive K+ channels.

Authors:  Katja Heusser; Hebao Yuan; Ioana Neagoe; Andrei I Tarasov; Frances M Ashcroft; Blanche Schwappach
Journal:  J Cell Sci       Date:  2006-10-15       Impact factor: 5.285

7.  The PX-RICS-14-3-3zeta/theta complex couples N-cadherin-beta-catenin with dynein-dynactin to mediate its export from the endoplasmic reticulum.

Authors:  Tsutomu Nakamura; Tomoatsu Hayashi; Yuko Mimori-Kiyosue; Fumika Sakaue; Ken Matsuura; Shun-ichiro Iemura; Toru Natsume; Tetsu Akiyama
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

8.  N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.

Authors:  Jian-Guo Li; Chongguang Chen; Lee-Yuan Liu-Chen
Journal:  Biochemistry       Date:  2007-08-21       Impact factor: 3.162

Review 9.  Fine-tuning of GPCR activity by receptor-interacting proteins.

Authors:  Stefanie L Ritter; Randy A Hall
Journal:  Nat Rev Mol Cell Biol       Date:  2009-12       Impact factor: 94.444

Review 10.  Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients.

Authors:  Kaoru Nakao; Hidenori Mochizuki
Journal:  Drugs Today (Barc)       Date:  2009-05       Impact factor: 2.245

View more
  5 in total

1.  A G protein-coupled receptor (GPCR) in red: live cell imaging of the kappa opioid receptor-tdTomato fusion protein (KOPR-tdT) in neuronal cells.

Authors:  Peng Huang; Yi-Ting Chiu; Chongguang Chen; Yujun Wang; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Toxicol Methods       Date:  2013-07-12       Impact factor: 1.950

2.  Hypoxia Induces Internalization of κ-Opioid Receptor.

Authors:  Chunhua Xi; Xuan Liang; Chunhua Chen; Hasan Babazada; Tianzuo Li; Renyu Liu
Journal:  Anesthesiology       Date:  2017-05       Impact factor: 7.892

3.  Phosphoproteomics and bioinformatics analyses of spinal cord proteins in rats with morphine tolerance.

Authors:  Wen-Jinn Liaw; Cheng-Ming Tsao; Go-Shine Huang; Chin-Chen Wu; Shung-Tai Ho; Jhi-Joung Wang; Yuan-Xiang Tao; Hao-Ai Shui
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

4.  G-protein-coupled receptors mediate 14-3-3 signal transduction.

Authors:  Hua Li; Alex Eishingdrelo; Sathapana Kongsamut; Haifeng Eishingdrelo
Journal:  Signal Transduct Target Ther       Date:  2016-09-30

5.  14-3-3 signal adaptor and scaffold proteins mediate GPCR trafficking.

Authors:  Luwa Yuan; Shahar Barbash; Sathapana Kongsamut; Alex Eishingdrelo; Thomas P Sakmar; Haifeng Eishingdrelo
Journal:  Sci Rep       Date:  2019-08-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.